Trial site
Hopital Roger Salengro, CHU Lille
- 11running trials
- 11closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease5 trials
- Stroke3 trials
- Epilepsy2 trials
- Huntington's disease2 trials
- Parkinson disease2 trials
- Type 2 diabetes2 trials
- ALS (motor neurone disease)1 trial
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial
- Glioblastoma1 trial
- Hearing loss1 trial
- Heart failure1 trial
- Multiple sclerosis1 trial
- and 7 more
- Phase
- Phase 2/34 trials
- Phase 34 trials
- Phase 22 trials
- Status
- Completed6 trials
- Recruiting5 trials
- Active, not recruiting4 trials
- Terminated4 trials
- Not yet recruiting2 trials
- Withdrawn1 trial
- Lead sponsor
- University Hospital, Lille10 trials
- Washington University School of Medicine4 trials
- Biogen2 trials
- AB Science1 trial
- Cerenovus, Part of DePuy Synthes Products, Inc.1 trial
- and 4 more
Running trials
Recruiting
A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Prediction of Heart Failure and Cognitive Decline in Type 2 Diabetes
Recruiting
Evaluation of a New Communication Aid Tool to Favor Global Patient Centered Care
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease2 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Hearing loss1 recruiting
- Heart failure1 recruiting
- Parkinson disease1 recruiting
- Psoriasis1 recruiting
- Psoriatic arthritis1 recruiting
- Stroke1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Not yet recruiting
Active, not recruiting
Completed
Efficacy and Safety on SOM3355 in Huntington's Disease Chorea
Terminated
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Terminated
Study of Attentional Disorders in Patients Suffering From Idiopathic Generalized Epilepsy.
Terminated
Impact of Pharmaceutical Interviews on the Medication Adherence of Epileptic Patients
Completed
Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma
Completed
Markers of Disease Progression and Gait Within the Parkinsonian Population
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026